#33 - In a Sea of Studies: COVID-19 Vaccines, with Marek Doyle and Dr. Purvi Parikh

1:23:36
 
공유
 

Manage episode 303590455 series 2820441
Player FM과 저희 커뮤니티의 Christofer Lövgren 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

Christofer, Marek Doyle and Dr. Purvi Parikh speak about the COVID-19 vaccines in this episode of Do Explain. They discuss their effectiveness/efficacy, CDC's change in reporting of breakthrough infections, methodological limitations of certain studies, vaccine safety, comparing COVID-19 with the flu, natural immunity, self-reporting, and other related topics.
Marek Doyle is a functional nutritional therapist based in London, England. He has spent the last 15 years reconciling the data from 2,000 patient outcomes and 9,000 test results to build a model of personalized nutrition, and has been featured by a range of media, such as Sky Sports, the Daily Mail, Mens Health and Marie Claire.
Instagram: https://www.instagram.com/marekdoylenutrition
Website: https://www.marekdoyle.com/
Purvi Parikh, MD, is an immunologist and allergy specialist at NYU who has been involved in the Pfizer and AstraZeneca COVID-19 Vaccine Trials. Dr. Parikh practices in New York City at Allergy and Asthma Associates of Murray Hill and New York University School of Medicine. She also sits on the Board of Directors for the advocacy council of the American College of Allergy, Asthma & Immunology, and have appeared as a medical expert on CNN, CNBC and CBS News, among others.

Instagram: https://www.instagram.com/panipurvinyc
Twitter: https://twitter.com/purviparikhmd
[NOTE: References and additional comments for this discussion went over the allowed character limit and can instead be found in the following blog post on the Do Explain website: https://www.doexplain.org/episodes/33-in-a-sea-of-studies-covid-19-vaccines-with-marek-doyle-and-dr-purvi-parikh]
Support the podcast at:
patreon.com/doexplain (monthly)
ko-fi.com/doexplain (one-time)

42 에피소드